Robert Gallucci, DPM
Podiatrist · Warwick, RINPI 1275528549
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 10 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Acumed LLC at 32.5% of the total. Reporting peaked in 2022 at $153 and has fallen 64.1% since, to $55 in 2025. That places this record below the midpoint for podiatrist clinicians in RI, where the typical reported total is $377.
Across 10 payments — averaging $32.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acumed LLC$105
- Stryker$54
- Osteomed LLC$42
- Treace Medical Concepts, Inc.$36
- Orthofix Medical, Inc.$25
- Bioventus LLC$23
- plus $37 from 2 others
What the payments were for
- Food & beverage$323100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acumed LLC | 2 | $105 |
| Stryker | 1 | $54 |
| Osteomed LLC | 2 | $42 |
| Treace Medical Concepts, Inc. | 1 | $36 |
| Orthofix Medical, Inc. | 1 | $25 |
| Bioventus LLC | 1 | $23 |
| Lilly USA, LLC | 1 | $20 |
| Organogenesis Inc. | 1 | $17 |
How this compares
$323 in reported general payments places this provider in the 40th percentile of 29 podiatrist providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Colchicine | 48 | $2,730 |
| Betamethasone Dipropionate | 20 | $904 |
| Methylprednisolone | 94 | $860 |
| Gabapentin | 63 | $834 |
| Ammonium Lactate | 20 | $601 |
| Terbinafine Hcl | 51 | $535 |
| Celecoxib | 49 | $391 |
| Silver Sulfadiazine | 18 | $351 |
| Allopurinol | 40 | $323 |
| Levofloxacin | 28 | $169 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $118 |
| Cephalexin | 15 | $113 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Warwick
- Emily StefanskiWarwick$12K
- Andrew LemoiWarwick$11K
- George MonizWarwick$896
- Clyde FishWarwick$377
- Peter LewisWarwick$121
- Jonathan SabourinMiddletown$5K
- David ColanninoSmithfield$4K
- Bernard CoppolelliCoventry$2K
- Aaron MilamNorth Providence$2K
- Janice Therese BautistaProvidence$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.